Reported a net loss of $200 million due to heavy loan loss provisions.
Net interest income turned negative to -$15.1 million before loan loss provisions.
Management continues to execute share repurchases despite GAAP losses.
Significant debt maturities approaching in 2026-2029 requiring refinancing.
The Q1 2026 filing reveals a company at a critical inflection point, where the success of a high-stakes balance sheet surgery will determine its survival. The tension lies between the company's strong operational cash flow and its deteriorating asset quality. While the reduction in total assets reflects a strategic shedding of risk, the high percentage of non-accrual loans suggests that the 'cleanup' is an admission of permanent impairment rather than a strategic choice. Investors are essentially betting on whether management can bridge the gap to 2026 and beyond without a liquidity crisis. The massive gap between the current stock price and the reported NAV, combined with ongoing buybacks, suggests a deep divide between management's internal valuation and the market's perception of the company's solvency. The upcoming maturity of the 2026 notes will be the ultimate test of the bull thesis.